Company Introduction

 

  Sinomed is a professional medical consulting research agency, with professional research team, rich medical data resources and years of experience accumulated, focus on providing professional services on pharmaceutical and medical device including registration, R&D, license-in, all-round research, evaluation and consulting to variety of organizations in the pharmaceutical industry.

  *Mainly engaged in registration, R&D, license-in of pharmaceutical and medical device, also in consulting of new drugs, product line planning, IPO feasibility study report, acquisition evaluation, professional comb and assessment of enterprises information.
  *We have established a unique database, keeping track of domestic and foreign progress of research and authority review of new drugs, kind of pioneer here in China.
  *Customized and professional consultation services ~ for portfolio planning with strategic screening of new drugs and new products ~ for evaluation of market situation, production technology, clinical feasibility ~ for merger evaluation and for marketing contrive of new products .


   
Our Culture


  In good faith as a fundamental, guarantee for quality , provide professional standardized, high quality service for cooperation partners.In the new century, we are trying to improve their own quality, seize the opportunity to blaze new trails, and constantly better ourselves,Do medicine, do the most conscience medicine.


 

Our Team

  The company has 50 employees, including 100% of them have college diploma or above, 48 of them have professional and technical titles, including 10% of them have MD,10% of them have PhD.

  Management Team:

  Lifeng Wang

  Jeanna Cai

  Cody Yang

  BoTian

  Qiang Su

  Suyun Wang

  Xin Wang

Sales & Market Strategic Partner

Supor Southocean Pharma Co.Ltd.
Has the modern pharmaceutical production base with a production capacity of 3 billion has been completed and has passed the GMP certification across the board and is now in operation. The new base will move into three production bases and the aerosol research center and become a world-class pharmaceutical manufacturer with high-level production lines of solid preparations, liquid preparations, aerosols and tuberculosis drugs.

 

China National Pharmaceutical Foreign Trade Corporation
Founded in 1981, is a subsidiary of China National Pharmaceutical Group Corporation, a leading pharmaceutical enterprise group in China. Sinopharm Foreign Trade is mainly engaged in industrial investment and international trade in pharmaceuticals and related products, providing a wide range of value-added services such as information consultation and bonded business. Sinopharm Foreign Trade Continuous among the 500 largest import and export enterprises in China.


CSPC Pharmaceutical (Shijiazhuang ) Group
A large-scale Chinese pharmaceutical company, formed by four pharmaceutical companies on August 21, 1997, now has a total assets of 8 billion yuan, employs 18,000 people and owns 15 wholly-owned or holding subsidiaries, of which are located in Hong Kong Owned subsidiary of China National Pharmaceutical Group Co., Ltd. is China's pharmaceutical industry's first overseas listed company, is also Hong Kong's largest pharmaceutical companies. With the goal of creating a brand name for the Chinese pharmaceutical industry.


Zhejiang Hongji Pharma Co.Ltd.,
Founded in October 2015, The company has branch offices in Ningbo, Hangzhou and Shanghai. The company has independent import and export rights, business scope includes Chinese herbal medicine, Chinese medicine Pieces, proprietary Chinese medicines, chemical agents, chemical raw materials, antibiotics, antibiotics, APIs, biochemical drugs, one, two, three types of medical equipment, food, health products , Commodity wholesale and retail, marketing consulting services.